Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 742 | 0 | 3,824 |
| Gross Profit | N/A | N/A | 742 | N/A | 3,824 |
| Operating Expenses | 156,643 | 140,859 | 180,725 | 123,248 | 112,621 |
| Operating Income | -156,643 | -140,859 | -179,983 | -123,248 | -108,797 |
| Other Income | 23,410 | 24,856 | 18,789 | 10,947 | 10,499 |
| Pre-tax Income | -133,233 | -116,003 | -161,194 | -112,301 | -98,298 |
| Income Tax | N/A | N/A | 343 | -3,867 | N/A |
| Net Income Continuous | -133,233 | -116,003 | -161,537 | -108,434 | -98,298 |
| Net Income | $-133,233 | $-116,003 | $-161,537 | $-108,434 | $-98,298 |
| EPS Basic Total Ops | -0.81 | -0.70 | -1.23 | -0.99 | -0.92 |
| EPS Basic Continuous Ops | -0.81 | -0.70 | -1.23 | -0.99 | -0.92 |
| EPS Diluted Total Ops | -0.81 | -0.70 | -1.23 | -0.99 | -0.92 |
| EPS Diluted Continuous Ops | -0.81 | -0.70 | -1.23 | -0.99 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -0.70 | -1.14 | N/A | N/A |
| EBITDA(a) | $-164,748 | $-153,340 | $-185,758 | $-126,247 | $-111,875 |